Familial Beckwith‐Wiedemann syndrome in a multigenerational family: Forty years of careful phenotyping. Issue 2 (2nd November 2022)

• Record Type: Journal Article
• Authors: Best, Lyle G.; Duffy, Kelly A.; George, Andrew M.; Ganguly, Arupa; Kalish, Jennifer M.
• Is Part Of: American journal of medical genetics. Volume 191:Issue 2(2023)
• Page Start: 348
• Page End: 356
• Publication Date: 2022-11-02
• Subjects: anticipation -- Beckwith‐Wiedemann syndrome -- CDKN1C -- mosaicism; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.63026
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: Beckwith‐Wiedemann Spectrum (BWSp) is an overgrowth and cancer predisposition disorder characterized by a wide spectrum of phenotypic manifestations including macroglossia, abdominal wall defects, neonatal hypoglycemia, and predisposition to embryonal tumors. In 1981, Best and Hoekstra reported four patients with BWSp in a single family which suggested autosomal dominant inheritance, but standard clinical testing for BWSp was not available during this time. Meticulous phenotyping of this family has occurred over the past 40 years of follow‐up with additional family members being identified and samples collected for genetic testing. Genetic testing revealed a pathogenic mutation in CDKN1C, consistent with the most common cause of familial BWSp. CDKN1C mutations account for just 5% of sporadic cases of BWSp. Here, we report the variable presentation of BWSp across the individuals affected by the CDKN1C mutation and other extended family members spanning multiple generations, all examined by the same physician. Additional phenotypes thought to be atypical in patients with BWSp were reported which included cardiac abnormalities. The incidence of tumors was documented in extended family members and included rhabdomyosarcoma, astrocytoma, and thyroid carcinoma, which have previously been reported in patients with BWSp. These observations suggest that in addition to the inheritance of the CDKN1C variant, there are modifying factors in this family driving the phenotypic spectrum observed. Alternative theories are suggested to explain the etiology of clinical variability including diffused mosaicism, anticipation, and the presence of additional variants tracking in the family. This study highlights the necessity of long‐term follow‐up in patients with BWSp and consideration of individual familial characteristics in the context of phenotype and/or (epi)genotype associations.